The first participant has been dosed in Foresee's Phase 2 trial testing the experimental oral therapy mirivadelgat in people ...

A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

Between PH and a transplant, columnist Anna Jeter has often struggled with loneliness and isolation as someone with chronic ...

Patients and clinicians endorsed Opsynvi as a single-tablet combination therapy for PAH in interviews conducted during a ...

Using a machine-learned algorithm, Corvista's system can accurately diagnose pulmonary hypertension in a noninvasive way, a ...

Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...